NIH Research Matter – January 26, 2021
Opioid addiction | Heart transplant rejection | COVID-19 immunity
National Institutes of Health (NIH) sent this bulletin on 01/26/2021 02:00 PM EST
COVID-19 is an emerging, rapidly evolving situation, and we at NIH are doing everything we can toward the development of diagnostics, therapeutics, and vaccines. You can find the latest public health information from CDC at www.coronavirus.gov and the latest research information from NIH at https://www.covid19.nih.gov. Meanwhile, science continues to progress on many other fronts, and we will continue to try to bring you stories across a wide range of topics.
Physician-pharmacist collaboration may improve care for opioid addiction
In a pilot trial, a team approach to treating opioid use disorder that relies heavily on community pharmacists was effective and convenient.
Acute heart transplant rejection detected earlier with new test
Researchers found that a blood test can detect signs of acute heart transplant rejection earlier than more invasive tissue biopsies, the current standard.
Lasting immunity found after recovery from COVID-19
The immune systems of more than 95% of people who recovered from COVID-19 had durable memories of the virus up to eight months after infection.